Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial
Farzaneh Dastan, Seyed Alireza Nadji, Ali Saffaei, Majid Marjani, Afshin Moniri, Hamidreza Jamaati, Seyed MohammadReza Hashemian, Parvaneh Baghaei, Atefeh Abedini, Mohammad Varahram, Sahar Yousefian, Payam Tabarsi
Topics & Concepts
LopinavirHydroxychloroquineMedicineRitonavirLopinavir/ritonavirAdverse effectInternal medicineProspective cohort studyClinical trialInterferonCoronavirus disease 2019 (COVID-19)Viral loadPharmacologyVirusVirologyAntiretroviral therapyDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchRespiratory viral infections research